BioXcel Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Good morning, everyone. Welcome to the 39th Annual JPMorgan Healthcare Conference. My name is [Badi Shadler]. I'm a member of the JPMorgan healthcare investment banking team. Thank you for joining our next session this morning on BioXcel.
I'm going to hand it over to our next presenter, Vimal Mehta, CEO and Chairman of BioXcel. But before we start, I'd just like to remind everyone that we will have a Q&A session after prepared remarks. And you'll be able to submit a question to Vimal and the team through the blue submit a question button.
And with that, I'll hand it over to Vimal.
Thanks, [Badi]. Good morning, everyone. I'm Vimal Mehta, I'm CEO of BioXcel Therapeutics, a clinical-stage company utilizing artificial intelligence platform to develop innovative and transformative medicines in neuroscience and immuno-oncology.
Can you please put the first slide, please? Can we go to the next slide? Before I begin, as a
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |